BUZZ — HK — listed GenFleet jumps on positive progress of cancer drug

* Shares of China-based innovative drugs developer GenFleet Therapeutics (Shanghai) Inc jump 8.4% to HK$28.54, on track for the biggest one-day pct gain since September 30 * Stock touches highest level since October 12, snapping three straight sessions of losses * GenFleet announces positive progress in GFH375/VS-7375's clinical development for cancer treatment with latest data disclosed from multiple clinical studies in China and abroad reflecting promising efficacy in various ras sarcoma-mutant solid tumors * YTD, stock up 14.7%, Hang Seng Biotech Index up 5.2% (Reporting by Donny Kwok) ((donny.kwok@thomsonreuters.com)